Causeway Therapeutics, a clinical-stage biotechnology company developing novel medicines for tendon disease, today announced positive topline data from its Phase 2 clinical ...

Injection of a soft tissue repair matrix combined with platelet-rich plasma may significantly improve clinical outcomes among patients with lateral epicondylitis, according to published results.

Introduction Lateral epicondylitis is one of the most common causes of musculoskeletal pain involving common extensor origin of the forearm. Although the diagnosis of lateral epicondylitis is clear, ...

Please provide your email address to receive an email when new articles are posted on . Steroid injections are not going to change the natural history of lateral epicondylitis. Yao and colleagues ...

Feb. 28, 2005 (Washington) --- Whether a surgeon operates for lateral epicondylitis using an open, arthroscopic, or percutaneous method appears to have no significant effect on patient outcomes, ...

Introduction Chronic lateral elbow epicondylitis is a tendinosis with angiofibroblastic degeneration of the wrist extensors' origin. Electrolysis Percutaneous Intratissue (EPI) is a minimally invasive ...

A 48-year-old, right-hand-dominant woman had lateral epicondylitis that did not improve with conservative treatment, including rest, nonsteroidal anti-inflammatory medication, splinting, physical ...

DUBLIN--(BUSINESS WIRE)--The "Lateral Epicondylitis Market by Treatment Type, By End User, By Region; Trend Analysis, Competitive Market Share & Forecast, 2016-26" report has been added to ...